AB 3621 – New Jersey

Status: In Process
Year Introduced: 2024
Link: https://www.njleg.state.nj.us/bill-search/2024/A3621

Prohibits excessive increases in prices charged for essential off-patent and generic prescription drugs and biological products.

Return to Database Search

© 2018- The SLIHCQ DatabaseInitial funding for this project was provided by the Robert Wood Johnson Foundation. The views expressed here do not necessarily reflect the views of the Foundation.

Associated Litigation:

No items found